FLINT, Mich., Jan. 5, 2018 /PRNewswire/ — Diplomat Pharmacy, Inc. (NYSE: DPLO) has reaffirmed guidance for the full-year 2017 and provided a preliminary 2018 outlook.
Diplomat preliminarily expects 2017 revenue to be near the middle of the previously provided range and Adjusted…
